• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国硬皮病患者自发性皮肤消退及皮肤消退的预测因素。

Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients.

机构信息

Division of Allergy-Immunology-Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Clin Rheumatol. 2011 Sep;30(9):1235-40. doi: 10.1007/s10067-011-1744-z. Epub 2011 Apr 12.

DOI:10.1007/s10067-011-1744-z
PMID:21484224
Abstract

Skin tightness is a major clinical manifestation of systemic sclerosis (SSc). Importantly for both clinicians and patients, spontaneous regression of the fibrosis process has been documented. The purpose of this study is to identify the incidence and related clinical characteristics of spontaneous regression among Thai SSc patients. A historical cohort with 4 years of follow-up was performed among SSc patients over 15 years of age diagnosed with SSc between January 1, 2005 and December 31, 2006 in Khon Kaen, Thailand. The start date was the date of the first symptom and the end date was the date of the skin score ≤2. To estimate the respective probability of regression and to assess the associated factors, the Kaplan-Meier method and Cox regression analysis was used. One hundred seventeen cases of SSc were included with a female to male ratio of 1.5:1. Thirteen patients (11.1%) experienced regression. The incidence rate of spontaneous skin regression was 0.31 per 100 person-months and the average duration of SSc at the time of regression was 35.9±15.6 months (range, 15.7-60 months). The factors that negatively correlated with regression were (a) diffuse cutaneous type, (b) Raynaud's phenomenon, (c) esophageal dysmotility, and (d) colchicine treatment at onset with a respective hazard ratio (HR) of 0.19, 0.19, 0.26, and 0.20. By contrast, the factor that positively correlated with regression was active alveolitis with cyclophosphamide therapy at onset with an HR of 4.23 (95% CI, 1.23-14.10). After regression analysis, only Raynaud's phenomenon at onset and diffuse cutaneous type had a significantly negative correlation to regression. A spontaneous regression of the skin fibrosis process was not uncommon among Thai SSc patients. The factors suggesting a poor predictor for cutaneous manifestation were Raynaud's phenomenon, diffuse cutaneous type while early cyclophosphamide therapy might be related to a better skin outcome.

摘要

皮肤紧绷是系统性硬化症(SSc)的主要临床表现。重要的是,对于临床医生和患者来说,纤维化过程的自发消退已经得到证实。本研究的目的是确定泰国 SSc 患者自发消退的发生率和相关临床特征。在泰国孔敬,对 2005 年 1 月 1 日至 2006 年 12 月 31 日期间被诊断为 SSc 的年龄在 15 岁以上的 SSc 患者进行了为期 4 年的历史队列研究。起始日期为第一个症状出现的日期,截止日期为皮肤评分≤2 的日期。为了估计各自的回归概率并评估相关因素,使用 Kaplan-Meier 方法和 Cox 回归分析。共纳入 117 例 SSc 患者,男女比例为 1.5:1。13 例(11.1%)患者出现消退。自发性皮肤消退的发生率为 0.31/100 人-月,消退时 SSc 的平均持续时间为 35.9±15.6 个月(范围 15.7-60 个月)。与消退负相关的因素为(a)弥漫性皮肤型,(b)雷诺现象,(c)食管运动障碍和(d)在发病时使用秋水仙碱治疗,相应的风险比(HR)为 0.19、0.19、0.26 和 0.20。相比之下,与消退正相关的因素是在发病时用环磷酰胺治疗的活动性肺泡炎,其 HR 为 4.23(95%CI,1.23-14.10)。在回归分析后,只有发病时的雷诺现象和弥漫性皮肤型与消退有显著的负相关。泰国 SSc 患者的皮肤纤维化过程自发消退并不少见。提示皮肤表现不良预测因素的因素有雷诺现象、弥漫性皮肤型,而早期使用环磷酰胺治疗可能与更好的皮肤结局相关。

相似文献

1
Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients.泰国硬皮病患者自发性皮肤消退及皮肤消退的预测因素。
Clin Rheumatol. 2011 Sep;30(9):1235-40. doi: 10.1007/s10067-011-1744-z. Epub 2011 Apr 12.
2
Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.泰国抗拓扑异构酶I阳性与阴性系统性硬化症患者的临床差异
Int J Rheum Dis. 2016 Mar;19(3):312-20. doi: 10.1111/1756-185X.12492. Epub 2014 Oct 8.
3
Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.泰国系统性硬化症患者临床和自身抗体谱的相关性
Int J Rheum Dis. 2017 Oct;20(10):1572-1581. doi: 10.1111/1756-185X.13060. Epub 2017 Mar 10.
4
Time to diagnosis in systemic sclerosis: is sex a factor?系统性硬化症的诊断时间:性别是一个因素吗?
Arthritis Rheum. 2009 Feb 15;61(2):274-8. doi: 10.1002/art.24284.
5
Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry.系统性硬化症的性别与诊断时间:对加拿大硬皮病研究组登记处1129例患者的最新分析
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-10-4. Epub 2013 Oct 11.
6
Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.566 例泰国系统性硬化症患者的临床特征和结局:一项队列研究。
Int J Rheum Dis. 2020 Jul;23(7):945-957. doi: 10.1111/1756-185X.13859. Epub 2020 May 18.
7
Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.C 反应蛋白与系统性硬化症高疾病活动度的相关性:来自加拿大硬皮病研究组的研究结果。
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.
8
Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis.泰国系统性硬化症患者手部受累的患病率及预测因素
Int J Rheum Dis. 2018 Jan;21(1):240-248. doi: 10.1111/1756-185X.12919. Epub 2016 Jul 26.
9
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients.系统性硬化症患者皮肤血流灌注值与甲襞毛细血管镜检查评分之间的相关性
Microvasc Res. 2016 May;105:119-24. doi: 10.1016/j.mvr.2016.02.007. Epub 2016 Feb 18.
10
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.早期系统性硬化症患者的性别差异:来自 EULAR 硬皮病试验和研究组 (EUSTAR) 数据库的报告。
Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):68-75. Epub 2018 Sep 29.

引用本文的文献

1
Abnormal Esophageal Scintigraphy Associates With a Distinct Clinical Phenotype in Patients With Systemic Sclerosis.异常食管闪烁扫描与系统性硬化症患者独特的临床表型相关。
ACR Open Rheumatol. 2025 Jan;7(1):e11796. doi: 10.1002/acr2.11796.
2
Prevalence of erectile dysfunction in Thai scleroderma patients and associated factors.泰国硬皮病患者勃起功能障碍的患病率及相关因素。
PLoS One. 2023 Jan 19;18(1):e0279087. doi: 10.1371/journal.pone.0279087. eCollection 2023.
3
Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis.

本文引用的文献

1
Skin involvement in systemic sclerosis.系统性硬化症中的皮肤受累情况。
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v44-5. doi: 10.1093/rheumatology/ken309.
2
Outcome measures in rheumatologic clinical trials and systemic sclerosis.风湿病临床试验和系统性硬化症的结局指标。
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v29-30. doi: 10.1093/rheumatology/ken269.
3
Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity.硬皮病患者甲襞微血管镜检查模式与疾病亚型及疾病严重程度相关。
泰国系统性硬化症患者中肌少症的流行情况及其与临床的关联。
Sci Rep. 2022 Oct 28;12(1):18198. doi: 10.1038/s41598-022-21914-w.
4
Development and validation of machine learning for early mortality in systemic sclerosis.系统性硬皮病早期死亡的机器学习开发与验证。
Sci Rep. 2022 Oct 13;12(1):17178. doi: 10.1038/s41598-022-22161-9.
5
Renal pathology and clinical associations in systemic sclerosis: a historical cohort study.系统性硬化症的肾脏病理学与临床关联:一项历史性队列研究。
Int J Gen Med. 2019 Sep 2;12:323-331. doi: 10.2147/IJGM.S221471. eCollection 2019.
6
Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.系统性硬化症-肌炎重叠综合征严重吞咽困难的康复:一例报告
Afr Health Sci. 2017 Jun;17(2):593-596. doi: 10.4314/ahs.v17i2.38.
7
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries.系统性硬化症(SSc)中糖皮质激素(GC)使用的患病率及相关因素:队列研究和登记处的系统评价与荟萃分析
Clin Rheumatol. 2014 Feb;33(2):153-64. doi: 10.1007/s10067-013-2422-0. Epub 2013 Nov 19.
Rheumatology (Oxford). 2007 Oct;46(10):1566-9. doi: 10.1093/rheumatology/kem190. Epub 2007 Aug 10.
4
Skin involvement in scleroderma--where histological and clinical scores meet.硬皮病中的皮肤受累——组织学评分与临床评分的交汇之处
Rheumatology (Oxford). 2007 May;46(5):833-41. doi: 10.1093/rheumatology/kel451. Epub 2007 Jan 25.
5
Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.与系统性硬化症相关的雷诺现象的病理生理学及临床后果
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii33-5. doi: 10.1093/rheumatology/kel280.
6
Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.系统性硬化症患者血清细胞因子浓度的纵向分析:白细胞介素12升高与皮肤硬化自发消退的关联
J Rheumatol. 2006 Feb;33(2):275-84.
7
The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.口服环磷酰胺联合泼尼松龙治疗早期弥漫性系统性硬化症的疗效
Clin Rheumatol. 2003 Oct;22(4-5):289-94. doi: 10.1007/s10067-003-0733-2.
8
Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.口服环磷酰胺和泼尼松龙疗法对早期弥漫性系统性硬化症患者内皮功能及临床症状的影响
Arthritis Rheum. 2003 Aug;48(8):2256-61. doi: 10.1002/art.11081.
9
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.美国一大群人中系统性硬化症的患病率、发病率、生存率及疾病特征。
Arthritis Rheum. 2003 Aug;48(8):2246-55. doi: 10.1002/art.11073.
10
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.改良的罗德南皮肤评分是系统性硬化症中皮肤活检厚度的准确反映。
J Rheumatol. 1998 Jan;25(1):84-8.